Search results
PROMOTED
Added:
4 weeks ago
Brad Wilson (Radcliffe Cardiology) is joined by Dr Devi Nair, Course Director of Rhythm Interventions Online (RIO), for a conversation charting the evolution of one of the arrhythmia community's most distinctive global education platforms.Since its launch as a virtual meeting, RIO has grown into a major international forum for electrophysiology — bringing together thousands of physicians, diverse…
View more
Added:
2 weeks ago
HRS Congress 2026 — Prof Elad Anter (Yitzhak Shamir Medical Center, Beer Yakov, IL) joins us to discuss findings from a study investigating reentry at patient-specific atrial regions characterised by steep repolarisation gradients as a mechanism of atrial fibrillation in humans.Interview Questions:What is the current state of debate around reentry as a mechanism of AF, and what has been missing…
View more
Added:
1 week ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large…
View more
Added:
1 week ago
HRS Congress 2026 — In this interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr Pasquale Santangeli (Cleveland Clinic, Ohio) about the largest single-center US experience with the Medtronic dual-energy lattice tip catheter for ventricular tachycardia (VT) ablation.This platform combines radiofrequency (RF) ablation and pulsed field…
View more
Added:
1 year ago
AF Symposium 25 - Insights from the admIRE sub-analysis show that if a patient experiences an early recurrence of paroxysmal atrial fibrillation (PAF), they are likely to experience another recurrence, suggesting that the blanking period is not needed in pulsed field ablation (PFA).Dr Luigi Di Biase (Albert Einstein College of Medicine and Montefiore Medical Center, NY, US) joins us onsite at AF…
View more
Added:
9 months ago
Source:
Radcliffe CVRM
A prespecified secondary analysis of the EAST-AFNET 4 trial has found that the benefits of an early rhythm control strategy for patients with recently diagnosed atrial fibrillation (AF) are maintained regardless of whether patients have obesity or diabetes.¹ These findings suggest that clinicians should not withhold this therapeutic approach based on these common metabolic comorbidities.The…
View more
Added:
6 months ago
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, one key question emerges: How are these systems performing in real-world clinical practice? This on-demand version of the session takes you inside the lab to share practical perspectives from physicians at the forefront of PFA adoption.Chaired by Dr Jack McCready…
View more
Start date:
Nov 07, 2025
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, the most important question becomes: How are they performing in the real-world? This session will dive into the lab to share practical perspectives from physicians at the forefront of adoption. Join Dr Jack McCready(University Hospitals Sussex NHS Foundation Trust, UK)…
View more
Hakim Ben Amer
Job title: Interventional Cardiologist
Author
Wilhelm Haverkamp
Job title: Professor of Internal Medicine/Cardiology
Author